DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

OMPI 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.83

Sector

Healthcare

Industry

Drugs

Obagi Medical Products, Inc. (OMPI) Description

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems. Website: http://www.obagi.com/

News & Commentary Rss Feed

The Great Acquirer Strikes Again

But is this proposed merger of equals a mistake?

Valeant Pharmaceuticals International Completes Tender Offer for Obagi Medical Products

Canadian Market Climbs Nearly 130 Points, Holding Near Its Best Levels Of The Day

Valeant Pharma Reports Receipt of Approval from Antimonopoly Committee of Ukraine for Obagi Offer

Valeant Receives Extension of Expiration Date for Tender Offer of Obagi

Valeant Pharma Announces Receipt of Antitrust Clearance in US for Previously-Announced Acquisition o

Valeant Pharma Announces Receipt of Antitrust Clearance in US for Previously-Announced Acquisition of Obagi

Mario Gabelli - Active Trading LUFK, SUP, OMPI

Mario Gabelli - Active Trading LUFK, SUP, OMPI

Mario Gabelli - Active Trading LUFK, SUP, OMPI

Mario Gabelli - Active Trading LUFK, SUP, OMPI

This Bidding War Was a Bidding Skirmish

The bidding war for Obagi Medical Products is over, and everyone's a winner.

Valeant: The Sole Suitor for Obagi - Analyst Blog

Valeant: The Sole Suitor for Obagi - Analyst Blog

See More OMPI News...

OMPI's Top Competitors

OMPI 0.00 (0.00%)
Current stock: OMPI
JNJ $98.96 (0.21%)
Current stock: JNJ
NVS $84.67 (0.31%)
Current stock: NVS
RHHBY $36.22 (0.14%)
Current stock: RHHBY